Evaluation of dosing strategy for pembrolizumab for oncology indications
Crossref DOI link: https://doi.org/10.1186/s40425-017-0242-5
Published Online: 2017-05-16
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freshwater, Tomoko
Kondic, Anna
Ahamadi, Malidi
Li, Claire H.
de Greef, Rik
de Alwis, Dinesh
Stone, Julie A.
Funding for this research was provided by:
Merck